Nautilus Biotechnology: Vijay Pande, Michael Altman

Nautilus Biotechnology said that Vijay Pande and Michael Altman have informed the company that they will not stand for re-election to its board of directors. Their decision is not due to any disagreement with the company related to its operations, policies, or practices, Nautilus said.